GAO Report, FDA: Better Coordination Could Enhance Efforts to Address Economic Adulteration and Protect the Public Health

This Government Accountability Office (GAO) report examines FDA’s approaches to detecting and preventing economic adulteration of food and medical products. The report notes the challenges FDA faces in detecting and preventing such adulteration, but concludes, "FDA may not be making the best use of its scarce resources.” The full report is available here.